patient_id	feature_display	tested_subfeature	therapy_name	n_mut	n_wt	n_mut_tested	n_wt_tested	mut_ic50_median	mut_ic50_mean	mut_ic50_std	wt_ic50_median	wt_ic50_mean	wt_ic50_std	pvalue_mww	statistic
KIRP-AL-3472	MET Amplification	MET	Crizotinib	199	1624	106	631	24.738	58.372	90.106	25.537	55.528	104.041	0.878	33754.0
KIRP-AL-3472	MET Amplification	MET Copy Number	Crizotinib	117	1706	60	677	24.822	57.83	90.407	25.427	55.769	103.133	0.928	20454.0
KIRP-AL-3472	MET Amplification	MET Copy Number Amplification	Crizotinib	82	1741	42	695	18.828	59.826	100.235	25.554	55.702	102.28	0.59	15317.0
KIRP-AL-3472	MET p.V1088E (Missense)	MET	SU11274	199	1624	123	801	58.163	79.735	81.446	42.785	68.665	76.237	0.129	45080.0
KIRP-AL-3472	MET p.V1088E (Missense)	MET Somatic Variant	SU11274	88	1735	57	867	50.407	79.148	84.131	43.459	69.547	76.52	0.485	23347.0
KIRP-AL-3472	MET p.V1088E (Missense)	MET Somatic Variant Missense	SU11274	74	1749	46	878	52.016	72.185	69.765	43.659	70.032	77.392	0.663	19425.0
KIRP-AL-3472	MET p.V1088E (Missense)	MET Somatic Variant Missense p.V1088E	SU11274	0	1823	0	924				44.064	70.139	76.997	nan	
